Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ViroMed Co. Ltd.

www.viromed.co.kr

Latest From ViroMed Co. Ltd.

Korean Biotech Sentiment Still Shaky But IPO Recovery Seen By Year-End

After a lackluster year so far for South Korean biotech IPOs amid disappointing clinical trial news, investor interest is beginning to pick up, with several companies that have been under the spotlight slated to debut on the market in the coming months.
South Korea Financing

Gene And Cell Therapies In Asia: New Korean Law To Change Landscape Of Cutting Edge Biologics

South Korea will undergo many changes as it gears up for a new law on cutting edge regenerative medicine and biologics, which will be implemented next year. Until then, further discussions will be needed to set details of the rules that can step up the industry’s competitiveness and bring the country more in line with global standards.

South Korea Gene Therapy

Gene And Cell Therapies In Asia: New Korean Law To Change Landscape Of Cutting Edge Biologics

South Korea will undergo many changes as it gears up for a new law on cutting edge regenerative medicine and biologics, which will be implemented next year. Until then, further discussions will be needed to set details of the rules that can step up the industry’s competitiveness and bring the country more in line with global standards.

South Korea Gene Therapy

Stempeutics Eyes Global Markets For New Crohn's Symptom Cell Therapy

Stempeutics explores stem cell therapy in India for Crohn’s disease-related perianal fistulae while considering entry into other Asian markets.

Research & Development India
See All

Company Information

  • Industry
  • Biotechnology
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Alias(es)
  • ViroMed Ltd.
  • VM BioPharma
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • South Korea
  • Parent & Subsidiaries
  • ViroMed Co. Ltd.
  • Senior Management
  • Yongsoo Kim, PhD, Pres. & CEO
    Sungchul Kim, CFO
    Sunyoung Kim, CSO
  • Contact Info
  • ViroMed Co. Ltd.
    Phone: (82)
    5th Floor, Bldg. 203, Seoul Nat'l Univ.
    599 Gwanak-ro
    Seoul, 151-747
    South Korea
UsernamePublicRestriction

Register